Clinical Trial Update: New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

View source ↗

Summary

A clinical trial is investigating a biomarker-based strategy to screen and monitor Activated PI3K delta syndrome, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Activated Pi3k-delta Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Activated PI3K Delta Syndrome | Status: RECRUITING